Lehrstuhl für Geburtshilfe und Frauenheilkunde

The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer (2019) Banys-Paluchowski M, Witzel I, Aktas B, Fasching P, Hartkopf A, Janni W, Kasimir-Bauer S, et al. Journal article Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: Results of the single-arm, phase IIIB 4EVER trial (2019) Tesch H, Stoetzer O, Decker T, Kurbacher CM, Marme F, Schneeweiss A, Mundhenke C, et al. Journal article Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer (2019) Von Minckwitz G, Huang CS, Mano MS, Loibl S, Mamounas EP, Untch M, Wolmark N, et al. Journal article Quality of life and oncological outcome in endometrial cancer patients after vaginal brachytherapy: comparison of two dosing schemes (2019) Papathemelis T, Scharl S, Hipp M, Scharl A, Beckmann M, Lux MP, Koelbl O Journal article Electrospun patterned porous scaffolds for the support of ovarian follicles growth: a feasibility study (2019) Liverani L, Amir F, Raffel N, Preis A, Hoffmann I, Boccaccini AR, Beckmann M, Dittrich R Journal article, Original article Venöse Luftembolie bei vaginalen Verletzungen durch Geschlechtsverkehr (2019) Zack F, Zinka B, Beckmann M, Banaschak S, Fischer H, Gabriel P, Gerber B, et al. Journal article Translational highlights in breast cancer research and treatment: recent developments with clinical impact (2019) Fasching P, Schneeweiss A, Kolberg HC, Ettl J, Fehm TN, Overkamp F, Lueftner D Journal article, Review article Circulating tumor cells in metastatic breast cancer: clinical relevance and biological potential (2019) Arkadius P, Marie T, Fabienne S, Thomas WPF, Brigitte R, Andreas H, Fasching P, et al. Journal article, Review article Permacol collagen paste for cryptoglandular and Crohn's anal fistula (2019) Brunner M, Schneider IHF, Guenther K, Grützmann R, Matzel K Journal article The impact of mammalian target of rapamycin inhibition on bone health in postmenopausal women with hormone receptor-positive advanced breast cancer receiving everolimus plus exemestane in the phase IIIb 4EVER trial (2019) Hadji P, Stoetzer O, Decker T, Kurbacher CM, Marme F, Schneeweiss A, Mundhenke C, et al. Journal article